Tuberculosis News and Research

Latest Tuberculosis News and Research

Microgravity and prolonged space flight could give unique advantages to germs

The cabin of a spacecraft halfway to Mars would be the least convenient place -- one cannot say "on earth" -- for a Salmonella or Pneumococcus outbreak, but a wide-ranging new paper suggests that microgravity and prolonged space flight could give unique advantages to germs.

22 Oct 2012

Aidspan publishes new issue of 'Global Fund Observer'

Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, on Thursday published Issue 199 of its "Global Fund Observer."

20 Oct 2012

Older antibiotic shows success in treating drug-resistant TB in small study

"An antibiotic used to treat severe bacterial infections showed promise at treating a highly drug-resistant and deadly form of tuberculosis [TB]," according to a study conducted by U.S. government and South Korean researchers and published in the New England Journal of Medicine on Wednesday, Reuters reports (Steenhuysen, 10/17).

20 Oct 2012

Canadian journal examines HIV in Swaziland

The Canadian Medical Association Journal reports on HIV in the Kingdom of Swaziland, writing the country "now has the dubious distinction of having the world's highest rate of both HIV and tuberculosis (TB)."

20 Oct 2012

Linezolid proves effective in treating drug-resistant TB

When tested in patients hospitalized with extensively drug-resistant tuberculosis (XDR-TB) unresponsive to previous treatment, linezolid, an antibiotic used to treat severe bacterial infections, proved largely effective when added to the patients' ongoing TB treatment regimen.

19 Oct 2012

Number of new TB infections fall, but drug resistance, lack of funding could slow progress, WHO reports

"New tuberculosis [TB] infections dropped 2.2 percent worldwide last year, but with nearly nine million new infections, the World Health Organization said TB remains a massive problem that could worsen if countries shortchange funding to fight it," Reuters reports.

19 Oct 2012

TB Alliance and FIND partner to promote development of TB drugs and diagnostics

A new partnership announced today will increase efforts to coordinate the development of complementary novel tools to fight TB, including drug-resistant TB, and identify emerging drug resistance trends around the globe.

19 Oct 2012

Global anti-tuberculosis campaign now ‘at a crossroads’

Tuberculosis care and control has improved dramatically over the last two decades, but numbers of cases and deaths are still high and multidrug resistant-TB is an under-reported and ever-increasing problem, suggest findings from the World Health Organization Global TB Report 2012.

18 Oct 2012

Trial results of first new TB vaccine candidate in 90 years expected next year

"Researchers will find out early next year whether the first new vaccine against tuberculosis [TB] for 90 years protects against a disease that was once neglected but is now resurgent worldwide," Financial Times reports.

18 Oct 2012

Global Fund invites Myanmar to apply for additional funding

"Health workers in Myanmar are confident that efforts to narrow the country's huge gap between access to, and need for, life-saving medicines to treat HIV/AIDS are back on track after the Global Fund to Fight AIDS, Tuberculosis and Malaria invited the country to apply for additional funding," IRIN reports.

17 Oct 2012

New initiative aims to bolster human resources at medical schools in Rwanda

U.S. Global AIDS Coordinator Ambassador Eric Goosby is "expected to announce a new initiative between the U.S. government, the Rwandan Ministry of Health and 14 American medical schools at a press conference Monday in Kigali, Rwanda," the New York Times reports.

16 Oct 2012

U.N. report shows francophone African countries lag behind in AIDS Treatment; NGOs call for increased funding

"Despite great progress within a short time, the 29 French-speaking countries of sub-Saharan Africa are lagging far behind other states in the region in the battle against HIV/AIDS and need a massive increase in international aid, according to a United Nations report" released Friday, the U.N. News Centre reports.

16 Oct 2012

NIH to accelerate development and application of single cell analysis across various fields

The National Institutes of Health plans to invest more than $90 million over five years, contingent upon the availability of funds, to accelerate the development and application of single cell analysis across a variety of fields.

16 Oct 2012

Aidspan publishes new issue of 'Global Fund Observer'

Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, on Monday published Issue 198 of its "Global Fund Observer."

15 Oct 2012

GlaxoSmithKline to make clinical trial data available to other researchers

GlaxoSmithKline (GSK) CEO Andrew Witty "said on Thursday detailed data from its clinical trials would be made available to other researchers," Reuters reports, adding, "That would include anonymized patient-level results that sit behind clinical trials of approved and failed drugs."

15 Oct 2012

S. African National AIDS Council CEO speaks to PlusNews about reform, funding

Fareed Abdullah, CEO of the South African National AIDS Council (SANAC), who took office in July, spoke with PlusNews regarding the body's reform, the revival of provincial AIDS councils, resource mobilization, and the appointment of a new board that allows SANAC to operate independently.

15 Oct 2012

Global Fund, Churches Health Association of Zambia sign grant agreement worth $102M

"The Global Fund to Fight AIDS, Tuberculosis and Malaria signed a grant agreement worth $102 million with the Churches Health Association of Zambia [CHAZ] Wednesday," Devex's "Development Newswire" reports.

13 Oct 2012

FDA expands approved indication for Genentech’s ACTEMRA to treat active rheumatoid arthritis

Genentech, Inc., a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) has expanded the approved indication for ACTEMRA (tocilizumab) for the treatment of adults with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response to one or more disease-modifying antirheumatic drugs (DMARDs).

13 Oct 2012

Mexican government, NGOs working to expand access to clean syringes to prevent HIV among IDUs

Inter Press Service examines how Mexico's government and non-governmental organizations are working to stem the spread of HIV among people who use injection drugs. "According to a project financed by the Global Fund to Fight AIDS, Tuberculosis and Malaria since 2011, the prevalence of HIV/AIDS in Mexico is 5.77 percent among intravenous drug users ... compared to 0.24 to 0.3 percent in the general population aged 15 to 49," IPS writes, noting HIV prevalence among drug users is highest in "northern Mexico, one of the areas in the country hit hardest by drug trafficking."

13 Oct 2012

Bureaucracy in India slowing treatment of TB, Wall Street Journal reports

The Wall Street Journal examines how bureaucracy in India is slowing the treatment of tuberculosis (TB) in the country. The newspaper recounts the story of Rahima Sheikh, "one of 16 patients identified by Mumbai doctors to be resistant to virtually all traditional TB treatments."

12 Oct 2012